Mirela Mačkić-Ðurović, E. Kiseljaković, I. Aganović-Mušinović, Admir Rasumović
{"title":"波黑人群中CFTR基因最常见的突变","authors":"Mirela Mačkić-Ðurović, E. Kiseljaković, I. Aganović-Mušinović, Admir Rasumović","doi":"10.9734/ajbgmb/2023/v14i3315","DOIUrl":null,"url":null,"abstract":"Aims: Cystic fibrosis is an autosomal recessive multisystem disease caused by a mutation of the CFTR gene. To date, more than 1900 mutations of this gene are known. Studies have shown that the most common mutation is delF508. In Bosnia and Herzegovina, the prevalence of individual mutations in the general population has not been thoroughly studied, so this study aimed to determine the prevalence of the mutation concerning the countries of the region and the rest of the world. \nStudy Design: Retrospective study. \nPlace and Duration of Study: Thirty-nine subjects with suspected Cystic fibrosis were referred to the Center for Genetics of the Medical Faculty in Sarajevo between 2018-2020. \nMethodology: 29 common CFTR gene mutations were analysed with the ELUCIGENE CF29 v2 kit (Elucigene Diagnostics, UK) using four multiplex PCR. \nResults: The most common mutation in our study was the F508 deletion, present in 14 subjects (73.68%). R347P and G542X mutations were confirmed in two subjects in the heterozygous state in combination with delF508 (M) 5.26% of each of these mutations. 621+1G>T was found in a homozygous state in one subject, while in another, it was in a heterozygous state in combination with delF508(M) mutation, 10.52%. Mutation 2184 delA was found in one subject in the homozygous state with a total frequency of 5.26%. \nConclusion: Subjects with cystic fibrosis in Bosnia and Herzegovina are most often carriers of the delF508 mutation. Considering the existence of many mutations and that it is difficult to test them all, targeting the most common mutations in a clinical environment might help in approving therapy, and increasing patients’ quality of life.","PeriodicalId":8498,"journal":{"name":"Asian Journal of Biochemistry, Genetics and Molecular Biology","volume":"466 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Most Common Mutations in the CFTR Gene in the Population of Bosnia and Herzegovina\",\"authors\":\"Mirela Mačkić-Ðurović, E. Kiseljaković, I. Aganović-Mušinović, Admir Rasumović\",\"doi\":\"10.9734/ajbgmb/2023/v14i3315\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aims: Cystic fibrosis is an autosomal recessive multisystem disease caused by a mutation of the CFTR gene. To date, more than 1900 mutations of this gene are known. Studies have shown that the most common mutation is delF508. In Bosnia and Herzegovina, the prevalence of individual mutations in the general population has not been thoroughly studied, so this study aimed to determine the prevalence of the mutation concerning the countries of the region and the rest of the world. \\nStudy Design: Retrospective study. \\nPlace and Duration of Study: Thirty-nine subjects with suspected Cystic fibrosis were referred to the Center for Genetics of the Medical Faculty in Sarajevo between 2018-2020. \\nMethodology: 29 common CFTR gene mutations were analysed with the ELUCIGENE CF29 v2 kit (Elucigene Diagnostics, UK) using four multiplex PCR. \\nResults: The most common mutation in our study was the F508 deletion, present in 14 subjects (73.68%). R347P and G542X mutations were confirmed in two subjects in the heterozygous state in combination with delF508 (M) 5.26% of each of these mutations. 621+1G>T was found in a homozygous state in one subject, while in another, it was in a heterozygous state in combination with delF508(M) mutation, 10.52%. Mutation 2184 delA was found in one subject in the homozygous state with a total frequency of 5.26%. \\nConclusion: Subjects with cystic fibrosis in Bosnia and Herzegovina are most often carriers of the delF508 mutation. Considering the existence of many mutations and that it is difficult to test them all, targeting the most common mutations in a clinical environment might help in approving therapy, and increasing patients’ quality of life.\",\"PeriodicalId\":8498,\"journal\":{\"name\":\"Asian Journal of Biochemistry, Genetics and Molecular Biology\",\"volume\":\"466 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Asian Journal of Biochemistry, Genetics and Molecular Biology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.9734/ajbgmb/2023/v14i3315\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Biochemistry, Genetics and Molecular Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/ajbgmb/2023/v14i3315","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的:囊性纤维化是由CFTR基因突变引起的常染色体隐性多系统疾病。迄今为止,已知该基因有1900多种突变。研究表明,最常见的突变是delF508。在波斯尼亚和黑塞哥维那,尚未对一般人群中个体突变的流行率进行彻底研究,因此本研究旨在确定该区域各国和世界其他地区的突变流行率。研究设计:回顾性研究。研究地点和时间:2018-2020年期间,39名疑似囊性纤维化的受试者被转介到萨拉热窝医学院遗传学中心。方法:29个常见的CFTR基因突变用illumigene CF29 v2试剂盒(illumigene Diagnostics, UK)进行4次多重PCR分析。结果:本研究中最常见的突变为F508缺失,共有14例(73.68%)。R347P和G542X突变在两名杂合状态的受试者中被证实,delF508 (M)各占5.26%。621+1G>T与delF508(M)突变合并为杂合状态,在1例受试者中发现为纯合状态,在1例受试者中发现为杂合状态,占10.52%。突变2184 delA 1例,纯合状态,总频率为5.26%。结论:波黑囊性纤维化患者是delF508突变的最常见携带者。考虑到存在许多突变,并且很难对它们全部进行测试,在临床环境中针对最常见的突变可能有助于批准治疗,并提高患者的生活质量。
The Most Common Mutations in the CFTR Gene in the Population of Bosnia and Herzegovina
Aims: Cystic fibrosis is an autosomal recessive multisystem disease caused by a mutation of the CFTR gene. To date, more than 1900 mutations of this gene are known. Studies have shown that the most common mutation is delF508. In Bosnia and Herzegovina, the prevalence of individual mutations in the general population has not been thoroughly studied, so this study aimed to determine the prevalence of the mutation concerning the countries of the region and the rest of the world.
Study Design: Retrospective study.
Place and Duration of Study: Thirty-nine subjects with suspected Cystic fibrosis were referred to the Center for Genetics of the Medical Faculty in Sarajevo between 2018-2020.
Methodology: 29 common CFTR gene mutations were analysed with the ELUCIGENE CF29 v2 kit (Elucigene Diagnostics, UK) using four multiplex PCR.
Results: The most common mutation in our study was the F508 deletion, present in 14 subjects (73.68%). R347P and G542X mutations were confirmed in two subjects in the heterozygous state in combination with delF508 (M) 5.26% of each of these mutations. 621+1G>T was found in a homozygous state in one subject, while in another, it was in a heterozygous state in combination with delF508(M) mutation, 10.52%. Mutation 2184 delA was found in one subject in the homozygous state with a total frequency of 5.26%.
Conclusion: Subjects with cystic fibrosis in Bosnia and Herzegovina are most often carriers of the delF508 mutation. Considering the existence of many mutations and that it is difficult to test them all, targeting the most common mutations in a clinical environment might help in approving therapy, and increasing patients’ quality of life.